Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 120, Issue 7, Pages 11104-11114Publisher
WILEY
DOI: 10.1002/jcb.28387
Keywords
Aurora A; computational mapping; hotspots; protein-protein docking; S155R mutant; TPX2; virtual screening
Categories
Funding
- Science and Engineering Research Board
Ask authors/readers for more resources
Aurora A is a mitotic serine/threonine kinase protein that is a proposed target of the first-line anticancer drug design. It has been found to be overexpressed in many human cancer cells, including hematological, breast, and colorectal. Here, we focus on a particular somatic mutant S155R of Aurora kinase A protein, whose activity decreases because of loss of interaction with a TPX2 protein that results in ectopic expression of the Aurora kinase A protein, which contributes chromosome instability, centrosome amplification, and oncogenic transformation. The primary target of this study is to select a drug molecule whose binding results in gaining S155R mutant interaction with TPX2. The computational methodology applied in this study involves mapping of hotspots (for uncompetitive binding), virtual screening, protein-ligand docking, postdocking optimization, and protein-protein docking approach. In this study, we screen and validate ZINC968264, which acts as a potential molecule that can improve the loss of function occurred because of mutation (S155R) in Aurora A. Our approaches pave a suitable path to design a potential drug against physiological condition manifested because of S155R mutant in Aurora A.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available